|
この項目「プロオピオメラノコルチン」は翻訳されたばかりのものです。不自然あるいは曖昧な表現などが含まれる可能性があり、このままでは読みづらいかもしれません。(原文:http://en.wikipedia.org/w/index.php?title=Proopiomelanocortin&oldid=492117162 英語版 "Proopiomelanocortin" 01:07, 12 May 2012)
修正、加筆に協力し、現在の表現をより原文に近づけて下さる方を求めています。ノートページや履歴も参照してください。(2012年6月) |
プロオピオメラノコルチン(副腎皮質刺激ホルモン/ β-リポトロピン/ α-メラノサイト刺激ホルモン/ β-メラノサイト刺激ホルモン/ β-エンドルフィン) |
識別記号 |
記号(英語版) |
POMC; LPH; MSH; ACTH; CLIP; NPP; POC |
その他ID |
OMIM(英語版): 176830 MGI(英語版): 97742 HomoloGene(英語版): 723 GeneCards: POMC Gene |
遺伝子オントロジー |
分子機能 |
• hormone activity
|
細胞の構成要素 |
• extracellular region
• soluble fraction
|
生物学的プロセス |
• generation of precursor metabolites and energy
• signal transduction
• neuropeptide signaling pathway
• cell-cell signaling
• blood pressure regulation
|
出典: Amigo / EGO |
|
RNA発現パターン |
|
その他参照発現データ |
オルソログ |
種 |
ヒト |
マウス |
|
Entrez(英語版) |
5443 |
18976 |
|
Ensembl(英語版) |
ENSG00000115138 |
ENSMUSG00000020660 |
|
UniProt(英語版) |
P01189 |
P01193 |
|
RefSeq (mRNA) |
NM_000939 |
NM_008895 |
|
RefSeq (protein) |
NP_000930 |
NP_032921 |
|
Location (UCSC) |
Chr 2:
25.24 - 25.25 Mb |
Chr 12:
3.95 - 3.96 Mb |
|
PubMed search |
[1] |
[2] |
|
|
POMCの切断 |
POMC |
|
|
|
γ-MSH |
ACTH |
β-lipotropin |
|
|
|
|
|
|
α-MSH |
CLIP |
γ-lipotropin |
β-エンドルフィン |
|
|
|
|
|
|
β-MSH |
|
|
Opioids neuropeptide |
識別子 |
略号 |
Op_neuropeptide |
Pfam |
PF08035 |
InterPro |
IPR013532 |
PROSITE |
PDOC00964 |
利用可能な蛋白質構造: |
Pfam |
structures |
PDB |
RCSB PDB; PDBe; PDBj |
PDBsum |
structure summary |
|
|
プロオピオメラノコルチン(英: Pro-opiomelanocortin, POMC)は、241個のアミノ酸残基からなるポリペプチド前駆体。285個のアミノ酸残基からなるポリペプチドのプレプロオピオメラノコルチン(pre-POMC)から作られる。pre-POMCの翻訳後プロセッシングにて44個のアミノ酸残基のシグナルペプチド配列が切除されPOMCとなる。POMC遺伝子は、2p23.3 染色体に位置する。
目次
- 1 POMC産生
- 2 翻訳後プロセッシング
- 3 関連項目
- 4 脚注
POMC産生
POMCは次の組織で産生されるが、主に産生されるのは下垂体の前葉と中葉である。
- 脳下垂体前葉の副腎皮質刺激ホルモン産生細胞
- 下垂体中葉のメラニン細胞刺激ホルモン産生細胞
- 視床下部弓状核にある約3000個の神経細胞[1]
- 視床下部背内側核および脳幹にある少数の細胞
- 皮膚のメラニン細胞
翻訳後プロセッシング
- 右図(POMCの切断)を参照
pre-POMCは、スブチリシン(英)様プロホルモン変換酵素による切断を経由して組織特異的な翻訳後プロセッシングを受ける。 POMCのプロセッシングにはグリコシル化、アセチル化、タンパク質分解性の切断がある。ただし、タンパク質分解酵素が切断する箇所は組織特異的である。
例えば、POMCが下垂体前葉の副腎皮質刺激ホルモン産生細胞において産生されると、4ヶ所切断されて副腎皮質刺激ホルモン(ACTH)とβ-リポトロピン(英)となる。
POMC内には、この他に少なくとも8つの切断可能な箇所があり、組織や変換酵素によって次に示す最大10の活性ペプチドが産生されうる。
- N-Terminal Peptide of Proopiomelanocortin(英) (NPP, or pro-γ-MSH)
- γ-メラニン細胞刺激ホルモン (γ-MSH)
- 副腎皮質刺激ホルモン (ACTH)
- α-メラニン細胞刺激ホルモン (α-MSH)
- Corticotropin-like Intermediate Peptide(英) (CLIP)
- β-リポトロピン(英) (β-LPH)
- γ-リポトロピン(英) (γ-LPH)
- β-メラニン細胞刺激ホルモン (β-MSH)
- β-エンドルフィン
- メチオニン-エンケファリン
切断箇所は、Arg-Lys, Lys-Arg あるいは Lys-Lys配列からなり、POMCペプチドのプロセッシングを行う酵素には、
- プロホルモン変換酵素1(英) (PC1)
- プロホルモン変換酵素2(英) (PC2)
- Carboxypeptidase E (英)(CPE)
- peptidyl α-amidating monooxygenase(英) (PAM)
- N-acetyltrasferase(英) (N-AT)
- prolylcarboxypeptidase(英) (PRCP)
がある。
関連項目
- Melanocortin(英)
- Afamelanotide(英)
- Melanotan II(英)
脚注
- ^ Cowley et al, Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus, Nature. 2001 May 24;411(6836):480-4.
Proopiomelanocortin |
Identifiers |
Symbols |
POMC ; ACTH; CLIP; LPH; MSH; NPP; POC |
External IDs |
OMIM: 176830 MGI: 97742 HomoloGene: 723 GeneCards: POMC Gene |
Gene ontology |
Molecular function |
• G-protein coupled receptor binding
• receptor binding
• hormone activity
• type 3 melanocortin receptor binding
• type 4 melanocortin receptor binding
• type 1 melanocortin receptor binding
|
Cellular component |
• extracellular region
• extracellular space
• cytoplasm
• peroxisome
• peroxisomal matrix
• secretory granule
• secretory granule lumen
|
Biological process |
• generation of precursor metabolites and energy
• signal transduction
• neuropeptide signaling pathway
• cell-cell signaling
• regulation of blood pressure
• peptide hormone processing
• regulation of appetite
• negative regulation of tumor necrosis factor production
• cellular pigmentation
• cellular protein metabolic process
• positive regulation of transcription from RNA polymerase II promoter
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
5443 |
18976 |
|
Ensembl |
ENSG00000115138 |
ENSMUSG00000020660 |
|
UniProt |
P01189 |
P01193 |
|
RefSeq (mRNA) |
NM_000939 |
NM_001278581 |
|
RefSeq (protein) |
NP_000930 |
NP_001265510 |
|
Location (UCSC) |
Chr 2:
25.38 – 25.39 Mb |
Chr 12:
3.95 – 3.96 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Opioids neuropeptide |
Identifiers |
Symbol |
Op_neuropeptide |
Pfam |
PF08035 |
InterPro |
IPR013532 |
PROSITE |
PDOC00964 |
Available protein structures: |
Pfam |
structures |
PDB |
RCSB PDB; PDBe; PDBj |
PDBsum |
structure summary |
|
Pro-opiomelanocortin (POMC) is a precursor polypeptide with 241 amino acid residues. POMC is synthesized from the 285-amino-acid-long polypeptide precursor pre-pro-opiomelanocortin (pre-POMC), by the removal of a 44-amino-acid-long signal peptide sequence during translation.
Contents
- 1 Function
- 2 Synthesis
- 3 Derivatives
- 4 Clinical significance
- 5 Interactions
- 6 See also
- 7 References
- 8 Further reading
- 9 External links
Function
POMC is cleaved to give rise to multiple peptide hormones. Each of these peptides is packaged in large dense-core vesicles that are released from the cells by exocytosis in response to appropriate stimulation:
- α-MSH produced by neurons in the arcuate nucleus has important roles in the regulation of appetite and sexual behavior, while α-MSH secreted from the intermediate lobe of the pituitary regulates the production of melanin.
- ACTH is a peptide hormone that regulates the secretion of glucocorticoids from the adrenal cortex.
- β-Endorphin and [Met]enkephalin are endogenous opioid peptides with widespread actions in the brain.
Synthesis
The POMC gene is located on chromosome 2p23.3. The POMC gene is expressed in both the anterior and intermediate lobes of the pituitary gland. This gene encodes a 285-amino acid polypeptide hormone precursor that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary, where four cleavage sites are used; adrenocorticotrophin (ACTH), essential for normal steroidogenesis and the maintenance of normal adrenal weight, and β-lipotropin are the major end-products. However, there are at least eight potential cleavage sites within the polypeptide precursor and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. Cleavage sites consist of the sequences Arg-Lys, Lys-Arg, or Lys-Lys. Enzymes responsible for processing of POMC peptides include prohormone convertase 1 (PC1), prohormone convertase 2 (PC2), carboxypeptidase E (CPE), peptidyl α-amidating monooxygenase (PAM), N-acetyltransferase (N-AT), and prolylcarboxypeptidase (PRCP).
The processing of POMC involves glycosylations, acetylations, and extensive proteolytic cleavage at sites shown to contain regions of basic protein sequences. However, the proteases that recognize these cleavage sites are tissue-specific. In some tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and β-lipotropin peptides.
It is synthesized by:
- Corticotrope cells of the anterior pituitary gland
- Melanotrope cells of the intermediate lobe of the pituitary gland
- 3,148±62 Neurons in the arcuate nucleus of the hypothalamus[1]
- Smaller populations of neurons in the dorsomedial hypothalamus and brainstem
- Melanocytes in the skin
Derivatives
proopiomelanocortin derivatives |
POMC |
|
|
|
γ-MSH |
ACTH |
β-lipotropin |
|
|
|
|
|
|
α-MSH |
CLIP |
γ-lipotropin |
β-endorphin |
|
|
|
|
|
|
β-MSH |
|
The large molecule of POMC is the source of several important biologically active substances. POMC can be cleaved enzymatically into the following peptides:
- N-Terminal Peptide of Proopiomelanocortin (NPP, or pro-γ-MSH)
- γ-Melanotropin (γ-MSH)
- Corticotropin (Adrenocorticotropic Hormone, or ACTH)
- α-Melanotropin (α-Melanocyte-Stimulating Hormone, or α-MSH)
- Corticotropin-like Intermediate Peptide (CLIP)
- β-Lipotropin (β-LPH)
- Lipotropin Gamma (γ-LPH)
- β-Melanotropin (β-MSH)
- β-Endorphin
- [Met]Enkephalin
Although the N-terminal 5 amino acids of β-endorphin are identical to the sequence of [Met]enkephalin, it is not generally thought that β-endorphin is converted into [Met]enkephalin.[citation needed] Instead, [Met]enkephalin is produced from its own precursor, proenkephalin A.
The production of β-MSH occurs in humans but not in mice or rats due to the absence of the enzymatic processing site in the rodent POMC.
Clinical significance
Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described.[2][3]
Interactions
Proopiomelanocortin has been shown to interact with melanocortin 4 receptor.[4][5]
See also
- Melanocortin
- Afamelanotide
- Melanotan II
References
- ^ Cowley MA, Smart JL, Rubinstein M, Cerdán MG, Diano S, Horvath TL et al. (May 2001). "Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus". Nature 411 (6836): 480–4. doi:10.1038/35078085. PMID 11373681.
- ^ "Entrez Gene: POMC proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin)".
- ^ Kuehnen P, Mischke M, Wiegand S, Sers C, Horsthemke B, Lau S et al. (2012). Yeo GS, ed. "An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity". PLoS Genet. 8 (3): e1002543. doi:10.1371/journal.pgen.1002543. PMC 3305357. PMID 22438814.
- ^ Yang YK, Fong TM, Dickinson CJ, Mao C, Li JY, Tota MR et al. (December 2000). "Molecular determinants of ligand binding to the human melanocortin-4 receptor". Biochemistry 39 (48): 14900–11. doi:10.1021/bi001684q. PMID 11101306.
- ^ Yang YK, Ollmann MM, Wilson BD, Dickinson C, Yamada T, Barsh GS et al. (March 1997). "Effects of recombinant agouti-signaling protein on melanocortin action". Mol. Endocrinol. 11 (3): 274–80. doi:10.1210/me.11.3.274. PMID 9058374.
Further reading
- Millington GW (May 2006). "Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors". Clin. Exp. Dermatol. 31 (3): 407–12. doi:10.1111/j.1365-2230.2006.02128.x. PMID 16681590.
- Millington GW (2007). "The role of proopiomelanocortin (POMC) neurones in feeding behaviour". Nutr Metab (Lond) 4: 18. doi:10.1186/1743-7075-4-18. PMC 2018708. PMID 17764572.
- Bhardwaj RS, Luger TA (1994). "Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis". Arch. Dermatol. Res. 287 (1): 85–90. doi:10.1007/BF00370724. PMID 7726641.
- Raffin-Sanson ML, de Keyzer Y, Bertagna X (2003). "Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions". Eur. J. Endocrinol. 149 (2): 79–90. doi:10.1530/eje.0.1490079. PMID 12887283.
- Dores RM, Lecaude S (2005). "Trends in the evolution of the proopiomelanocortin gene". Gen. Comp. Endocrinol. 142 (1-2): 81–93. doi:10.1016/j.ygcen.2005.02.003. PMID 15862552.
- König S, Luger TA, Scholzen TE (2006). "Monitoring neuropeptide-specific proteases: processing of the proopiomelanocortin peptides adrenocorticotropin and alpha-melanocyte-stimulating hormone in the skin". Exp. Dermatol. 15 (10): 751–61. doi:10.1111/j.1600-0625.2006.00472.x. PMID 16984256.
- Farooqi S, O'Rahilly S (2006). "Genetics of obesity in humans". Endocr. Rev. 27 (7): 710–18. doi:10.1210/er.2006-0040. PMID 17122358.
External links
- Pro-Opiomelanocortin at the US National Library of Medicine Medical Subject Headings (MeSH)
This article incorporates public domain material from websites or documents of the National Center for Biotechnology Information (Reference Sequence collection).
Hormones
|
|
Endocrine
glands |
Hypothalamic-
pituitary
|
Hypothalamus
|
- GnRH
- TRH
- Dopamine
- CRH
- GHRH/Somatostatin
- Melanin concentrating hormone
|
|
Posterior pituitary
|
|
|
Anterior pituitary
|
- α
- FSH
- FSHB
- LH
- LHB
- TSH
- TSHB
- CGA
- Prolactin
- POMC
- CLIP
- ACTH
- MSH
- Endorphins
- Lipotropin
- GH
|
|
|
Adrenal axis
|
- Adrenal cortex
- aldosterone
- cortisol
- DHEA
- Adrenal medulla
- epinephrine
- norepinephrine
|
|
Thyroid
|
- Thyroid hormone
- calcitonin
- Thyroid axis
|
|
Parathyroid
|
|
|
|
Gonadal axis
|
Testis
|
|
|
Ovary
|
- estradiol
- progesterone
- activin and inhibin
- relaxin (pregnancy)
|
|
Placenta
|
- hCG
- HPL
- estrogen
- progesterone
|
|
|
Pancreas
|
- glucagon
- insulin
- amylin
- somatostatin
- pancreatic polypeptide
|
|
Pineal gland
|
- melatonin
- N,N-dimethyltryptamine
- 5-methoxy-N,N-dimethyltryptamine
|
|
|
Other |
Thymus
|
- Thymosins
- Thymosin α1
- Beta thymosins
- Thymopoietin
- Thymulin
|
|
Digestive system
|
Stomach
|
|
|
Duodenum
|
- CCK
- Incretins
- secretin
- motilin
- VIP
|
|
Ileum
|
- enteroglucagon
- peptide YY
|
|
Liver/other
|
- Insulin-like growth factor
|
|
|
Adipose tissue
|
- leptin
- adiponectin
- resistin
|
|
Skeleton
|
|
|
Kidney
|
- JGA (renin)
- peritubular cells
- calcitriol
- prostaglandin
|
|
Heart
|
|
|
|
Index of hormones
|
|
Description |
- Glands
- Hormones
- thyroid
- mineralocorticoids
- Physiology
- Development
|
|
Disease |
- Diabetes
- Congenital
- Neoplasms and cancer
- Other
- Symptoms and signs
|
|
Treatment |
- Procedures
- Drugs
- calcium balance
- corticosteroids
- oral hypoglycemics
- pituitary and hypothalamic
- thyroid
|
|
|
Peptides: neuropeptides
|
|
Hormones |
see hormones
|
|
Opioid peptides |
Dynorphins
|
- Big dynorphin
- Dynorphin A
- Dynorphin B
- Leumorphin
|
|
Endomorphins
|
- Endomorphin-1
- Endomorphin-2
|
|
Endorphins
|
- α-Endorphin
- β-Endorphin
- γ-Endorphin
- α-Neoendorphin
- β-Neoendorphin
|
|
Enkephalins
|
- Met-enkephalin
- Leu-enkephalin
|
|
Others
|
- Adrenorphin
- Amidorphin
- Hemorphin
- Nociceptin
- Opiorphin
- Spinorphin
- Valorphin
|
|
|
Other
neuropeptides |
Kinins
|
- Tachykinins: mammal
- Substance P
- Neurokinin A
- Neurokinin B
- amphibian
|
|
Neuromedins
|
|
|
Other
|
- Angiotensin
- Bombesin
- Calcitonin gene-related peptide
- Carnosine
- Cocaine and amphetamine regulated transcript
- Delta sleep-inducing peptide
- FMRFamide
- Galanin
- Galanin-like peptide
- Gastrin releasing peptide
- Ghrelin
- Neuropeptide S
- Neuropeptide Y
- Neurophysins
- Neurotensin
- Pancreatic polypeptide
- Pituitary adenylate cyclase activating peptide
- RVD-Hpα
- VGF
|
|
|
Index of signal transduction
|
|
Description |
- Intercellular
- neuropeptides
- growth factors
- cytokines
- hormones
- Cell surface receptors
- ligand-gated
- enzyme-linked
- G protein-coupled
- immunoglobulin superfamily
- integrins
- neuropeptide
- growth factor
- cytokine
- Intracellular
- adaptor proteins
- GTP-binding
- MAP kinase
- Calcium signaling
- Lipid signaling
- Pathways
- hedgehog
- Wnt
- TGF beta
- MAPK ERK
- notch
- JAK-STAT
- apoptosis
- hippo
- TLR
|
|
|
Neuropeptidergics
|
|
CGRP |
- Agonists: Amylin
- CGRP
- Pramlintide
- Antagonists: BI 44370 TA
- BMS-927711
- CGRP (8-37)
- MK-3207
- Olcegepant
- Rimegepant
- SB-268262
- Telcagepant
- Ubrogepant
|
|
Cholecystokinin |
CCKA
|
- Agonists: Cholecystokinin
- CCK-4
- Antagonists: Amiglumide
- Asperlicin
- Devazepide
- Dexloxiglumide
- Lintitript
- Lorglumide
- Loxiglumide
- Pranazepide
- Proglumide
- Tarazepide
- Tomoglumide
|
|
CCKB
|
- Agonists: Cholecystokinin
- CCK-4
- Gastrin
- Antagonists: CI-988 (PD-134,308)
- Itriglumide
- L-365,360
- Netazepide
- Proglumide
- Spiroglumide
|
|
|
CRH |
CRF1
|
- Agonists: Cortagine
- Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Stressin I
- Urocortin
- Antagonists: Antalarmin
- Astressin-B
- CP-154,526
- Emicerfont
- Hypericin
- LWH-234
- NBI-27914
- Pexacerfont
- R-121,919
- TS-041
- Verucerfont
|
|
CRF2
|
- Agonists: Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Urocortin
|
|
|
Galanin |
GAL1
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin-like peptide
- Galmic
- Galnon
- Antagonists: C7
- Dithiepine-1,1,4,4-tetroxide
- Galantide (M15)
- M32
- M35
- M40
- SCH-202596
|
|
GAL2
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin (2-11)
- Galanin-like peptide
- Galmic
- Galnon
- J18
- Antagonists: C7
- Galantide (M15)
- M32
- M35
- M40
- M871
|
|
GAL3
|
- Agonists: Galanin
- Galanin (1-15)
- Galmic
- Galnon
- Antagonists: C7
- Galantide (M15)
- GalR3ant
- HT-2157
- M32
- M35
- M40
- SNAP-37889
- SNAP-398299
|
|
|
Ghrelin/GHS |
- Agonists: Adenosine
- Alexamorelin
- Anamorelin
- Capromorelin
- CP-464709
- Cortistatin-14
- Examorelin (hexarelin)
- Ghrelin (lenomorelin)
- GHRP-1
- GHRP-3
- GHRP-4
- GHRP-5
- GHRP-6
- Ibutamoren (MK-677)
- Ipamorelin
- L-692,585
- LY-426410
- LY-444711
- Macimorelin
- Pralmorelin (GHRP-2)
- Relamorelin
- SM-130,686
- Tabimorelin
- Ulimorelin
- Antagonists: A-778,193
- Cortistatin-8
- (D-Lys3)-GHRP-6
- YIL-781
|
|
MCH |
MCH1
|
- Agonists: Melanin concentrating hormone
- Antagonists: ATC-0065
- ATC-0175
- GW-803,430
- NGD-4715
- SNAP-7941
- SNAP-94847
|
|
MCH2
|
- Agonists: Melanin concentrating hormone
|
|
|
Melanocortin |
MC1
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- BMS-470,539
- Bremelanotide
- HS-014
- HS-024
- Melanotan II
- Modimelanotide
- PL-8177
- SHU-8914
- SHU-9005
- SHU-9119
- SNAP-7941
|
|
MC2
|
- Agonists: ACTH (corticotropin)
- Alsactide
- Codactide
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin, cosyntropin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
MC3
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- Bremelanotide
- Melanotan II
- Modimelanotide
- PG-931
- Antagonists: AGRP
- ASIP
- HS-014
- ML-00253764
- PG-106
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC4
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- AZD2820
- BIM-22493
- Bremelanotide
- LY-2112688
- Melanotan II
- MK-0493
- Modimelanotide
- PF-00446687
- PG-931
- PL-6983
- Ro 27-3225
- Setmelanotide
- THIQ
- Antagonists: AGRP
- ASIP
- HS-014
- HS-024
- HS-131
- JKC-363
- MCL-0020
- MCL-0042
- MCL-0129
- ML-00253764
- MPB-10
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC5
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- Bremelanotide
- HS-014
- HS-024
- Melanotan II
- Modimelanotide
- SHU-8914
- SHU-9005
- SHU-9119
- Antagonists: ASIP
- ML-00253764
|
|
Unsorted
|
- Agonists: Alsactide
- Codactide
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin, cosyntropin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
|
Neuropeptide S |
|
|
Neuropeptide Y |
Y1
|
- Agonists: Neuropeptide Y
- Peptide YY
- Antagonists: BIBO-3304
- BIBP-3226
- BVD-10
- GR-231,118
- PD-160,170
|
|
Y2
|
- Agonists: 2-Thiouridine 5'-triphosphate
- Neuropeptide Y
- Neuropeptide Y (13-36)
- Peptide YY
- Peptide YY (3-36)
- Antagonists: BIIE-0246
- JNJ-5207787
- SF-11
|
|
Y4
|
- Agonists: GR-231,118
- Neuropeptide Y
- Pancreatic polypeptide
- Peptide YY
|
|
Y5
|
- Agonists: BWX-46
- Neuropeptide Y
- Peptide YY
- Antagonists: CGP-71683
- FMS-586
- L-152,804
- Lu AA-33810
- MK-0557
- NTNCB
- Velneperit (S-2367)
|
|
|
Neurotensin |
NTS1
|
- Agonists: Neurotensin
- Neuromedin N
- Antagonists: Meclinertant
- SR-142,948
|
|
NTS2
|
- Antagonists: Levocabastine
- SR-142,948
|
|
|
Opioid |
See here instead.
|
|
Orexin |
OX1
|
- Agonists: Orexin-A
- Orexin-B
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- Filorexant
- Lemborexant
- SB-334,867
- SB-408,124
- SB-649,868
- Suvorexant
- TCS-1102
|
|
OX2
|
- Agonists: Orexin-A
- Orexin-B
- SB-668,875
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- EMPA
- Filorexant
- JNJ-10397049
- JNJ-42847922
- Lemborexant
- MK-1064
- SB-649,868
- Suvorexant
- TCS-1102
- TCS-OX2-29
|
|
|
Oxytocin |
- Agonists: Aspartocin
- Carbetocin
- Cargutocin
- Demoxytocin
- Merotocin
- Nacartocin
- Oxytocin
- TC OT 39
- TGOT
- Vasotocin (argiprestocin)
- WAY-267,464
- Antagonists: Atosiban
- Barusiban
- Epelsiban
- Erlosiban
- L-368,899
- L-371,257
- L-372,662
- OBE001
- Retosiban
- SSR-126,768
- Tocinoic acid
- WAY-162,720
|
|
Tachykinin |
NK1
|
- Antagonists: Aprepitant
- Befetupitant
- Burapitant
- Casopitant
- CI-1021
- CP-96,345
- CP-99,994
- CP-122,721
- Dapitant
- Ezlopitant
- Figopitant
- FK-888
- Fosaprepitant
- GR-203,040
- GW-597,599
- HSP-117
- L-733,060
- L-741,671
- L-743,310
- L-758,298
- Lanepitant
- LY-306,740
- Maropitant
- Netupitant
- NKP-608
- Nolpitantium besilate
- Orvepitant
- Rolapitant
- RP-67,580
- SDZ NKT 343
- Serlopitant
- Telmapitant
- Tradipitant
- Vestipitant
- Vofopitant
|
|
NK2
|
- Antagonists: GR-159,897
- Ibodutant
- Nepadutant
- Saredutant
|
|
NK3
|
- Antagonists: Osanetant
- Talnetant
|
|
|
Vasopressin |
V1A
|
- Agonists: Felypressin
- Lypressin
- Ornipressin
- Selepressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: Atosiban
- Conivaptan
- FR-218944
- JNJ-17079166
- JNJ-17308616
- LY-307174
- PF-184563
- Relcovaptan
- RG7314
- SRX246
- SRX251
- TC OT 39
- WAY-267,464
- YM-218
- YM-471
- YM-35471
|
|
V1B
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: ABT-436
- Nelivaptan
- ORG-52186
|
|
V2
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- TC OT 39
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: Conivaptan
- JNJ-17079166
- Lixivaptan
- Mozavaptan
- RWJ-351647
- Satavaptan
- Tolvaptan
- YM-471
- YM-35471
|
|
Unsorted
|
- Antagonists: Ribuvaptan
- RWJ-339489
- VMAX-367
- VMAX-372
- VMAX-382
- YM-222546
|
|
|
See also: Peptidergics
|
|